The options scandal continues to escalate for this corrupt health insurer:
Less than a month after ousting its CEO over the options scandal, the suburban Minneapolis health insurer told investors Nov. 8 that it expects to take “significantly greater” charges than the $286 million it had previously predicted. The company also said its financial statements for the past dozen years are suspect and shouldn’t be relied on, pending restatements. The reviews also will cause the company to delay filing its third-quarter report with the Securities & Exchange Commission.
